A protein kinase Cβ inhibitor attenuates multidrug resistance of neuroblastoma cells

BMC Cancer

Volumn 3, Issue , 2003, Pages

  Svensson, Karin ^a,b   Larsson, Christer ^a  

^a LUND UNIVERSITY   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ANTINEOPLASTIC AGENT; CARBOPLATIN; DOXORUBICIN; ETOPOSIDE; LY 379196; NATURAL PRODUCT; PACLITAXEL; PROTEIN KINASE C; PROTEIN KINASE C BETA; PROTEIN KINASE C INHIBITOR; VINCRISTINE; 5,21 - 12,17-DIMETHENEO-18H-DIBENZO(I,O)PYRROLO(3,4-1)(1,8)DIAZACYCLOHEXANDECINE-18,10(19H)DIONE,8((DIMETHYLAMINO)METHYL)-6,7,8,9,10,11-HEXAHYDRO,MONOMETHANESULFONATE; 5,21 12,17 DIMETHENEO 18H DIBENZO(I,O)PYRROLO(3,4 1)(1,8)DIAZACYCLOHEXANDECINE 18,10(19H)DIONE,8((DIMETHYLAMINO)METHYL) 6,7,8,9,10,11 HEXAHYDRO,MONOMETHANESULFONATE; BISINDOLYLMALEIMIDE I; INDOLE DERIVATIVE; MALEIMIDE DERIVATIVE; MESYLIC ACID DERIVATIVE; PYRROLE DERIVATIVE;

ARTICLE; ATTENUATION; CANCER INHIBITION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG POTENTIATION; DRUG SENSITIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; NEUROBLASTOMA CELL; TREATMENT OUTCOME; DRUG ANTAGONISM; DRUG RESISTANCE; NEUROBLASTOMA; PERIPHERAL NERVE TUMOR; TUMOR CELL CULTURE; TUMOR CELL LINE;

CARBOPLATIN; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; HUMANS; INDOLES; MALEIMIDES; MESYLATES; NEUROBLASTOMA; PACLITAXEL; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; PROTEIN KINASE C; PYRROLES; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 3042834127     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-3-10     Document Type: Article

References (38)

1. Evans AE Neuroblastoma: A historical perspective 1864-1998 In: Neuroblastoma (Edited by: Brodeur GM, Sawada T, Tsuchida Y, Voû te PA) Amsterdam: Elsevier Science B.V 2000, 1-7
2. Keshelava N, Seeger R, Groshen S and Reynolds C Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy Cancer Res 1998, 58:5396-5405
3. Mellor H and Parker PJ The extended protein kinase C family Biochem J 1998, 332:281-292
4. Zeidman R, Pettersson L, Ranga PS, Truedsson E, Fagerström S, Påhlman S and Larsson C Novel and classical isoforms have different functions in proliferation, survival and differentiation of neuroblastoma cells Int J Cancer 1999, 81:494-501
5. Svensson K, Zeidman R, Trollér U, Schultz A and Larsson C PKCβI is implicated in the regulation of neuroblastoma cell growth and proliferation Cell Growth Differ 2000, 11:641-648
6. Zeidman R, Löfgren B, Påhlman S and Larsson C PKCe, via its regulatory domain and independently of its catalytic domain, induces neurite-like processes in neuroblastoma cells J Cell Biol 1999, 145:713-726
7. Zeidman R, Trollér U, Raghunath A, Påhlman S and Larsson C Protein kinase Ce actin-binding site is important for neurite outgrowth during neuronal differentiation Mol Biol Cell 2002, 13:12-24
8. Bourhis J, Benard J, Hartmann O, Boccon-Gibod L, Lemerle J and Riou G Correlation of MDR1 gene expression with chemotherapy in neuroblastoma J Natl Cancer Inst 1989, 81:1401-5
9. Goldstein LJ, Fojo AT, Ueda K, Crist W, Green A, Brodeur G, Pastan I and Gottesman MM Expression of the multidrug resistance, MDR1, gene in neuroblastomas J Clin Oncol 1990, 8:128-36
10. Haber M, Bordow SB, Haber PS, Marshall GM, Stewart BW and Norris MD The prognostic value of MDR1 gene expression in primary untreated neuroblastoma Eur J Cancer 1997, 33:2031-6
11. Nakagawara A, Kadomatsu K, Sato S, Kohno K, Takano H, Akazawa K, Nose Y and Kuwano M Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas Cancer Res 1990, 50:3043-7
12. Obana K and Hashizume K Expression of multidrug resistance-related P-glycoprotein shows good prognosis in neuroblastoma J Pediatr Surg 1997, 32:420-2
13. Norris MD, Bordow SB, Marshall GM, Haber PS, Cohn SL and Haber M Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma N Engl J Med 1996, 334:231-238
14. Matsunaga T, Shirasawa H, Hishiki T, Enomoto H, Kouchi K, Ohtsuka Y, Iwai J, Yoshida H, Tanabe M and Kobayashi S Expression of MRP and cMOAT in childhood neuroblastomas and malignant liver tumors and its relevance to clinical behavior Jpn J Cancer Res 1998, 89:1276-83
15. Goto H, Keshelava N, Matthay KK, Lukens JN, Gerbing RB, Stram DO, Seeger RC and Reynolds CP Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors Med Pediatr Oncol 2000, 35:619-22
16. Haber M, Bordow SB, Gilbert J, Madafiglio J, Kavallaris M, Marshall GM, Mechetner EB, Fruehauf JP, Tee L and Cohn SL Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells Oncogene 1999, 18:2777-82
17. Tweddle DA, Malcolm AJ, Bown N, Pearson ADJ and Lunec J Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line Cancer Res 2001, 61:8-13
18. Keshelava N, Zuo JJ, Chen P, Waidyaratne SN, Luna MC, Gomer CJ, Triche TJ and Reynolds CP Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines Cancer Res 2001, 61:6185-6193
19. Duesberg P, Stindl R and Hehlmann R Origin of multidrug resistance in cells with and without multidrug resistance genes: Chromosome reassortments catalyzed by aneuploidy Proc Natl Acad Sci USA 2001, 98:11283-11288
20. Yanagisawa T, Newman A, Coley H, Renshaw J, Pinkerton CR and Pritchard-Jones K BIRICODAR (VX-710; Incel): an effective chemosensitizer in neuroblastoma Br J Cancer 1999, 80:1190-6
21. Norris MD, Madafiglio J, Gilbert J, Marshall GM and Haber M Reversal of multidrug resistance-associated protein-mediated drug resistance in cultured human neuroblastoma cells by the quinolone antibiotic difloxacin Med Pediatr Oncol 2001, 36:177-80
22. Chambers TC, McAvoy EM, Jacobs JW and Eilon G Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells J Biol Chem 1990, 265:7679-86
23. Blobe GC, Sachs CW, Khan WA, Fabbro D, Stabel S, Wetsel WC, Obeid LM, Fine RL and Hannun YA Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha J Biol Chem 1993, 268:658-64
24. Bates SE, Lee JS, Dickstein B, Spolyar M and Fojo AT Differential modulation of P-glycoprotein transport by protein kinase inhibition Biochemistry 1993, 32:9156-64
25. Ma LD, Marquardt D, Takemoto L and Center MS Analysis of P-glycoprotein phosphorylation in HL60 cells isolated for resistance to vincristine J Biol Chem 1991, 266:5593-9
26. Germann UA, Chambers TC, Ambudkar SV, Licht T, Cardarelli CO, Pastan I and Gottesman MM Characterization of phosphorylation-defective mutants of human P-glycoprotein expressed in mammalian cells J Biol Chem 1996, 271:1708-1716
27. Goodfellow HR, Sardini A, Ruetz S, Callaghan R, Gros P, McNaughton PA and Higgins CF Protein kinase C-mediated phosphorylation does not regulate drug transport by the human multidrug resistance P-glycoprotein J Biol Chem 1996, 271:13668-13674
28. Gekeler V, Boer R, Uberall F, Ise W, Schubert C, Utz I, Hofmann J, Sanders KH, Schachtele C and Klemm K Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance Br J Cancer 1996, 74:897-905
29. Gekeler V, Boer R, Ise W, Sanders KH, Schachtele C and Beck J The specific bisindolylmaleimide PKC-inhibitor GF 109203X efficiently modulates MRP-associated multiple drug resistance Biochem Biophys Res Commun 1995, 206:119-26
30. Merritt JE, Sullivan JA, Drew L, Khan A, Wilson K, Mulqueen M, Harris W, Bradshaw D, Hill CH and Rumsby M The bisindolylmaleimide protein kinase C inhibitor, Ro 32-reverses multidrug resistance in KB tumour cells Cancer Chemother Pharmacol 1999, 43:371-8
31. Sachs CW, Safa AR, Harrison SD and Fine RL Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C J Biol Chem 1995, 270:26639-26648
32. Bergman PJ, Gravitt KR, Ward NE, Beltran P, Gupta KP and O'Brian CA Potent induction of human colon cancer cell uptake of chemotherapeutic drugs by N-myristoylated protein kinase C-alpha (PKC-alpha) pseudosubstrate peptides through a Pglycoprotein-independent mechanism Invest New Drugs 1997, 15:311-8
33. Bergman PJ, Gravitt KR and O'Brian CA An N-myristoylated protein kinase C-alpha pseudosubstrate peptide that functions as a multidrug resistance reversal agent in human breast cancer cells is not a P-glycoprotein substrate Cancer Chemother Pharmacol 1997, 40:453-6
34. Ghayur T, Hugunin M, Talanian RV, Ratnofsky S, Quinlan C, Emoto Y, Pandey P, Datta R, Huang Y and Kharbanda S Proteolytic activation of protein kinase C δ by an ICE/CED 3-like protease induces characteristics of apoptosis J Exp Med 1996, 184:2399-2404
35. Majumder PK, Pandey P, Sun X, Cheng K, Datta R, Saxena S, Kharbanda S and Kufe D Mitochondrial translocation of protein kinase C delta in phorbol ester-induced cytochrome c release and apoptosis J Biol Chem 2000, 275:21793-6
36. Reyland ME, Anderson SM, Matassa AA, Barzen KA and Quissell DO Protein kinase C delta is essential for etoposide-induced apoptosis in salivary gland acinar cells J Biol Chem 1999, 274:19115-19123
37. Fujii T, Garcia-Bermejo ML, Bernabo JL, Caamano J, Ohba M, Kuroki T, Li L, Yuspa SH and Kazanietz MG Involvement of protein Kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta J Biol Chem 2000, 275:7574-7582
38. Khwaja A and Tatton L Caspase-mediated proteolysis and activation of protein kinase Cdelta plays a central role in neutrophil apoptosis Blood 1999, 94:291-301s